Skip to main content
PMC home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 2003 May;95(5):328–334.

Comparative analysis of lipid profiles among patients with type 2 diabetes mellitus, hypertension and concurrent type 2 diabetes, and hypertension: a view of metabolic syndrome.

S A Isezuo 1, S L H Badung 1, A B O Omotoso 1
PMCID: PMC2594520  PMID: 12793789

Abstract

Type 2 diabetes mellitus and hypertension are independent risk factors for atherosclerotic lesions that are partly linked with dyslipidaemia. This risk is additive when diabetes and hypertension occur concurrently. In order to determine if concurrent type 2 diabetes and hypertension results in putative increases in dyslipidaemia in a Nigerian population, we compared the plasma lipid levels, atherogenic index and prevalence of dyslipidaemia among age and sex-matched indigenous Nigerians with type 2 diabetes, hypertension and concurrent diabetes and hypertension. Age and sex-matched healthy Nigerians that are free of diabetes and hypertension served as controls. The patients as a whole were more likely to have dyslipidaemia than controls (p < 0.05). High-density lipoprotein cholesterol was similar among patients and controls. Mean total cholesterol, high-density lipoprotein cholesterol; low-density lipoprotein cholesterol and triglyceride levels, atherogenic index and prevalence of dyslipidaemia did not differ significantly among patients with hypertension, diabetes, and concurrent hypertension and diabetes (p = 0.99 for each parameter). It is concluded that concurrent hypertension and type 2 diabetes does not result in a more severe dyslipidaemia than when either of the two conditions occurs in isolation. We attribute this to the common pathogenic link between hypertension, diabetes and dyslipidaemia in metabolic syndrome. Evidence, albeit indirect, of this syndrome among native Africans is, therefore, provided.

Full text

PDF
328

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adedeji O. O., Onitiri A. C. Plasma lipids in Nigerian hypertensives. Afr J Med Med Sci. 1990 Dec;19(4):281–284. [PubMed] [Google Scholar]
  2. Aduba O., Onwuamaeze I., Oli J., Udeozo K. Serum cholesterol and high density lipoprotein cholesterol in Nigerian diabetics. East Afr Med J. 1984 Jan;61(1):35–39. [PubMed] [Google Scholar]
  3. Aitman T. J., Glazier A. M., Wallace C. A., Cooper L. D., Norsworthy P. J., Wahid F. N., Al-Majali K. M., Trembling P. M., Mann C. J., Shoulders C. C. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet. 1999 Jan;21(1):76–83. doi: 10.1038/5013. [DOI] [PubMed] [Google Scholar]
  4. Betteridge D. J. Diabetic dyslipidaemia. Eur J Clin Invest. 1999 Jun;29 (Suppl 2):12–16. doi: 10.1046/j.1365-2362.1999.00002.x. [DOI] [PubMed] [Google Scholar]
  5. Burstein M., Scholnick H. R., Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res. 1970 Nov;11(6):583–595. [PubMed] [Google Scholar]
  6. Friedewald W. T., Levy R. I., Fredrickson D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972 Jun;18(6):499–502. [PubMed] [Google Scholar]
  7. Giner V., Coca A., de la Sierra A. Increased insulin resistance in salt sensitive essential hypertension. J Hum Hypertens. 2001 Jul;15(7):481–485. doi: 10.1038/sj.jhh.1001216. [DOI] [PubMed] [Google Scholar]
  8. Hotamisligil G. S. The role of TNFalpha and TNF receptors in obesity and insulin resistance. J Intern Med. 1999 Jun;245(6):621–625. doi: 10.1046/j.1365-2796.1999.00490.x. [DOI] [PubMed] [Google Scholar]
  9. Knuiman J. T., Hermus R. J., Hautvast J. G. Serum total and high density lipoprotein (HDL) cholesterol concentrations in rural and urban boys from 16 countries. Atherosclerosis. 1980 Aug;36(4):529–537. doi: 10.1016/0021-9150(80)90245-2. [DOI] [PubMed] [Google Scholar]
  10. LEVINE J. B., ZAK B. AUTOMATED DETERMINATION OF SERUM TOTAL CHOLESTEROL. Clin Chim Acta. 1964 Oct;10:381–384. doi: 10.1016/0009-8981(64)90073-7. [DOI] [PubMed] [Google Scholar]
  11. Levy L. F. Atherosclerosis in Rhodesia. Afr J Med Sci. 1971 Jul;2(3):229–238. [PubMed] [Google Scholar]
  12. McGowan M. W., Artiss J. D., Strandbergh D. R., Zak B. A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem. 1983 Mar;29(3):538–542. [PubMed] [Google Scholar]
  13. Olubodun J. O., Falase A. O., Cole T. O. Drug compliance in hypertensive Nigerians with and without heart failure. Int J Cardiol. 1990 May;27(2):229–234. doi: 10.1016/0167-5273(90)90164-z. [DOI] [PubMed] [Google Scholar]
  14. Reaven G. M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988 Dec;37(12):1595–1607. doi: 10.2337/diab.37.12.1595. [DOI] [PubMed] [Google Scholar]
  15. Reaven G. M., Lithell H., Landsberg L. Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system. N Engl J Med. 1996 Feb 8;334(6):374–381. doi: 10.1056/NEJM199602083340607. [DOI] [PubMed] [Google Scholar]
  16. Riccardi G., Rivellese A. A. Effects of dietary fiber and carbohydrate on glucose and lipoprotein metabolism in diabetic patients. Diabetes Care. 1991 Dec;14(12):1115–1125. doi: 10.2337/diacare.14.12.1115. [DOI] [PubMed] [Google Scholar]
  17. Sevanian A., Asatryan L., Ziouzenkova O. Low density lipoprotein (LDL) modification: basic concepts and relationship to atherosclerosis. Blood Purif. 1999;17(2-3):66–78. doi: 10.1159/000014378. [DOI] [PubMed] [Google Scholar]
  18. Shamiss A., Carroll J., Rosenthal T. Insulin resistance in secondary hypertension. Am J Hypertens. 1992 Jan;5(1):26–28. doi: 10.1093/ajh/5.1.26. [DOI] [PubMed] [Google Scholar]
  19. Sharma M. D., Pavlik V. N. Dyslipidaemia in African Americans, Hispanics and whites with type 2 diabetes mellitus and hypertension. Diabetes Obes Metab. 2001 Feb;3(1):41–45. doi: 10.1046/j.1463-1326.2001.00113.x. [DOI] [PubMed] [Google Scholar]
  20. Stamler J., Vaccaro O., Neaton J. D., Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993 Feb;16(2):434–444. doi: 10.2337/diacare.16.2.434. [DOI] [PubMed] [Google Scholar]
  21. Trinder P. Determination of blood glucose using 4-amino phenazone as oxygen acceptor. J Clin Pathol. 1969 Mar;22(2):246–246. doi: 10.1136/jcp.22.2.246-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Vergès B. L. Dyslipidaemia in diabetes mellitus. Review of the main lipoprotein abnormalities and their consequences on the development of atherogenesis. Diabetes Metab. 1999 Jun;25 (Suppl 3):32–40. [PubMed] [Google Scholar]
  23. Wannamethee S. G., Shaper A. G., Durrington P. N., Perry I. J. Hypertension, serum insulin, obesity and the metabolic syndrome. J Hum Hypertens. 1998 Nov;12(11):735–741. doi: 10.1038/sj.jhh.1000714. [DOI] [PubMed] [Google Scholar]
  24. Witztum J. L. The oxidation hypothesis of atherosclerosis. Lancet. 1994 Sep 17;344(8925):793–795. doi: 10.1016/s0140-6736(94)92346-9. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES